Agenda – Precon/Day 1

Neil Bearden is an Associate Professor of Decision Sciences at INSEAD. He holds a PhD in Cognitive Psychology from The University of North Carolina at Chapel Hill.

He teaches courses on decision making, storytelling, and ethics. He himself is the subject of his current experiments. The main research question is “How can we improve our daily practices in order to increase our performance and live excellent human lives?”

Neil Bearden is co-directing the INSEAD Leadership Programme for Senior Executives – India.

Campbell Clark is Vice President, Legal and Compliance, Asia Pacific, for Medtronic, a healthcare company, and is based in Singapore. He was previously Chief Ethics & Compliance Officer, Asia Pacific, for Medtronic. Prior to Medtronic’s acquisition of Covidien in 2015, he was General Counsel, Asia, for Covidien. Campbell has also held senior roles in-house as an international legal counsel in Australia and Japan, and in private practice as a litigation lawyer in New Zealand and the United Kingdom. Since 2015 Campbell has been the Chair of the Legal/Ethics & Compliance Committee of the Asia Pacific Medical Technology Association (APACMed).

Holger has been Managing Director of the Association of Voluntary Self-Regulation for the Pharma-ceutical Industry (Freiwillige Selbstkontrolle für die Arzneimittelindustrie e.V. – FSA) since January 2012. Holger previously worked in the legal department of the German Association of Research-based Pharmaceutical Companies (Verband der forschenden Arzneimittelindustrie e.V.–vfa). He is Vice Chair of the Codes Committee and member of the Ethics and Compliance Committee at EFPIA. Holger is also a Vice Chair of the IFPMA Ethics and Business Integrity Committee (eBIC). Moreover, he is a Member of the International Society of Healthcare Ethics and Compliance Professionals (ETH-ICS).

Mr. HOW Ti-Hwei is the Country President of AstraZeneca Singapore, a UK-based science-led biopharmaceutical company focused on delivering life-changing medicines in 3 main therapeutic areas – Cardiovascular, Renal & Metabolic conditions, Respiratory diseases and Oncology. He is also the current President of the Singapore Association of Pharmaceutical Industries (SAPI), the Chair of European Chamber of Commerce (EuroCham) Healthcare Committee, and a member of the Ngee Ann Polytechnic Life Sciences Advisory Committee. Ti-Hwei has had 16 years of Marketing experience across both Pharmaceutical & FMCG industries before taking on different country leadership roles in the last 6 years. Outside of Singapore, he has lived and worked in Thailand, the Philippines, Vietnam and Malaysia.

Chrisoula Nikidis is the Canadian Head of Compliance and Ethics Solutions at IQVIA. A dedicated leader in the field of compliance, ethics, governance and stakeholder relations in the innovative medicines and life science sectors, Chrisoula’s successful career is highlighted by creative citizen mobilization, coalition-building and the development of ethical practices on a provincial, national and international level.

She has built a reputation as a trusted and respected leader of issues involving ethics and integrity both in the private and public sectors. She was previously the Executive Director, Ethics and Compliance for Innovative Medicines Canada.

Chrisoula has played a pivotal role in the advancement of compliance and ethics on the provincial, national and international level through her leadership in the Code of Ethical Practices as well as with her work with IFPMA and the APEC Biopharmaceutical Ethics Initiative.

Ms. Thakerar is a seasoned and experienced legal and compliance UK solicitor with 17 years’ experience as regional General Counsel APAC. She has 23 years in-house pharmaceutical industry experience with GlaxoSmithKline. Ms. Thakerar was previously with Kimberly Clark and was in private practice in London. Since 2000 she has been based in Singapore as regional General Counsel APAC.

Currently, Ms. Thakerar is an Associate member respectively of APACMed, Singapore Academy of Law, SIArb, Singapore Corporate Counsel Association and co-convenor of its Well-Being Chapter.

She is an experienced manager of large in house legal/compliance teams, legal budgets; external legal services spend/managing external law firms. Her experience is in project, transaction, stakeholder management and organization skills complex matrix management and legal/regulatory/investigations (FCPA/U.K. Bribery Act advisory work). Ms. Thakerar is also experienced in business and functions (finance/tax/HR/supply chain/procurement) partner and crisis management.

Cahyani Endahayu is a Partner in the Mergers & Acquisitions Practice Group. Her work includes handling the corporate/licensing, compliance and day-to-day work of several of the Firm’s major clients and providing corporate, compliance and advisory support services to other clients in relation to corporate/commercial issues. She has advised a wide range of domestic and international clients across various industry sectors, including pharmaceutical and retail/trading. Cahyani’s experience includes the representation of various pharmaceutical companies and providing regulatory advice on investment, product registrations (including transfer of registration of drug products) and licensing requirements at the local authorities. Her past experience includes representing multi-national pharmaceutical manufacturing companies in areas of contracts, clinical/observational studies contracts/agreements, providing regulatory advice on product labelling, compliance with Indonesian anti-corruption law and antitrust related matters. She is a Member of the Indonesian Advocates Association (PERADI).

Yunjoh Lee is an attorney at Kim & Chang. She practices primarily in health and antitrust and competition.

Ms. Lee counsels multinational clients in the pharmaceutical, medical device and food industries on Korean regulatory compliance, corporate governance, competition law issues, and general corporate and commercial law matters. In particular, Ms. Lee counsels drug and device clients on various facets of anti-corruption compliance, such as designing and implementing effective compliance programs, employee training, monitoring, internal investigations, corrective action and remedial measures.

Her representative matters include representing pharmaceutical companies in investigations by the Korea Fair Trade Commission into alleged competition law violations relating to marketing and sales practices and defending pharmaceutical companies before the Korea Fair Trade Commission and the Ministry of Food & Drug Safety on charges of illegal interactions with healthcare professionals.

Eddie Chuah is a partner with the Dispute Resolution Practice Group, with experience in all aspects of civil litigation, arbitration, industrial relations disputes and compliance.

Eddie has undertaken a wide variety of briefs involving substantive law issues ranging from complex commercial transactions, insolvency litigation, shareholder disputes, construction, employment and administrative law. He also focuses on compliance issues, in particular, anti-corruption investigation, government procurement, audit and prevention.

Eddie regularly advises and assists both domestic and multinational corporations on a broad range of risk-related issues in compliance with both local and foreign authorities. His experience includes conducting internal investigations and audits, developing internal policies and procedures, as well as providing the necessary training to mitigate risks of fraud and corruption.

He has assisted and represented major corporations on external investigations by the Department of Justice and Securities Exchange Commission, the United Kingdom Serious Fraud Office, Singapore Corrupt Practices Investigation Bureau as well as the Malaysian Anti-Corruption Commission Agency.

Mr. Nguyen Xuan is the Chief of Compliance Officer (Vietnam/ Indochina) for Sanofi Aventis. Previously, he was the Head of Compliance at CHUBB Life Vietnam. He also held several roles at Metro Cash & Carry, including Head of Security, Audit and Compliance, Head of Security, Head of LPO and Compliance, Head of Audit & Local Program Office (LPO) and Head of Audit.

Maria Eugenia (Maru) Quindimil is currently APAC Ethics and Compliance Head for UCB. She handles an extensive geography, from Japan to India to Australia and leads the team of 20 people between direct and indirect reports. She is handling not only internal compliance processes but also third parties and alliance management for APAC. Previously, Maru was Senior Director APAC at GEC Risk Advisory LLC, and Executive Director, Regional Compliance Officer, Asia for Merck Sharp & Dohme, Asia Ltd. Throughout a career that has spanned 28 years, Maru has applied her background in pharmaceutical and pharmacological research into the commercial pharmaceutical sector where she led the development, launch and market growth of several new products across a diverse range of geographic sectors. Maru has led APEC Pharmaceutical sector meetings for the implementation of Pharmaceutical codes of conduct and active contributor in AP Compliance Network.

Campbell Clark is Vice President, Legal and Compliance, Asia Pacific, for Medtronic, a healthcare company, and is based in Singapore. He was previously Chief Ethics & Compliance Officer, Asia Pacific, for Medtronic. Prior to Medtronic’s acquisition of Covidien in 2015, he was General Counsel, Asia, for Covidien. Campbell has also held senior roles in-house as an international legal counsel in Australia and Japan, and in private practice as a litigation lawyer in New Zealand and the United Kingdom. Since 2015 Campbell has been the Chair of the Legal/Ethics & Compliance Committee of the Asia Pacific Medical Technology Association (APACMed).

Giuseppe “Pino” Falbo joined Shire in Dubai as Regional Compliance Head to continue to improve the Compliance framework and capabilities in one of the most dynamic regions in Shire (Russia & CIS, NEMEA and India). He started his career with the Italian economic police and was seconded for year to a Prosecutor Office, investigating commercial and bank frauds, corruption cases and environmental crimes. From there, he has worked for the United States Secret Service on transnational investigations (South/East Europe, MEA and USA) on bank, commercial and credit cards frauds, counterfeit US dollars and cybercrimes, consulted on anti-fraud matters and later founded a business intelligence and investigation company, Hawk Global. Pino was the Business Practices Officer at Novartis; responsible for the misconduct handling process across all divisions in Asia, Middle East, Africa and Latin America. He was also the first Regional Compliance Director for Asia & Russia with Alcon.

Chris Royal works within the Global Ethics & Compliance function at GSK as VP, Head of Ethics and Compliance Emerging Markets. Chris began his career in the pharmaceutical industry with GSK in London. During his tenure, Chris has developed a significant amount of risk and internal control experience by accepting roles of increasing responsibility in different areas of the organization in the UK, US, China and Singapore. Chris was with the Internal Audit group for about 8 years and was responsible for reviewing internal controls of GSK’s subsidiaries, branch offices and cross functional processes around the world, covering both financial and nonfinancial areas. He joined the Compliance organization originally as the Global Compliance Officer for GSK’s Dermatology Business Unit (Stiefel). In 2014, Chris took on the position as VP, Head of Ethics and Compliance in China and was recently promoted to head up the Asia Pacific and Japan region.

Mohit Grover is an Executive Director in Risk Consulting and leads the Life Sciences & Health Care industry in Southeast Asia. He is currently a Partner with Deloitte and was previously the IS Lead, Global Commercial Organization at Astra Zeneca. With 20 years of experience in Consulting and Life Sciences industries, he possesses in-depth expertise in enabling business growth strategies, transformations in Sales & Marketing, Finance and IT functions. He has extensive experience in delivering shared services, digital, enterprise applications and outsourcing initiatives.

Rachel Cooper joined Transparency International in November 2017 to lead the Pharma and Healthcare Programme’s flagship project on open contracting in the health sector and to drive change in policy and practice towards addressing corruption across the pharma and healthcare value chain. She joined TI-UK after a career in the British Foreign Office (including postings in Europe and Africa) and delivering global health projects with INGOs and medical royal colleges.

Dominique Laymand is Executive Vice-President, Chief Ethics and Compliance Officer at Ipsen. She leads the Ethics and Compliance team and program, based on a Business Integrity vision. In a former role, Dominique acted as EMEA Vice-President Compliance & Ethics at Bristol Myers Squibb. Dominique Laymand is Honorary President of ETHICS, International Society of Healthcare Ethics and Compliance Professionals, whose mission is to be recognized as an independent international association of professionals, which sets standards of Ethics and Compliance, and shapes and influences strategies in the changing Healthcare environment for the ultimate benefit of Patients and Society at large, contributing to the development of Ethics and Compliance professionals. Dominique is an active member of various Pharmaceutical Industry Associations and committees, proactively addressing Trust, Reputation and Compliance and Ethics matters. She also plays a key role in various industry associations and provides ethics and compliance education in many different arenas.

Gareth Lee is Vice President, Legal & Compliance for the Asia Pacific region at Cardinal Health and a member of its Global Legal & Compliance Committee, which is tasked with driving the company’s legal & compliance strategy as it expands its global footprint. He also serves on Cardinal Health’s Asia Pacific leadership team where he provides broad and risk-weighted perspectives on business strategies and operations. With 24 years of experience as a legal professional, Gareth started his legal career in 1995 as a solicitor in the commercial & banking practice of a leading Singapore law firm and thereafter as legal counsel with increasing scope and responsibilities in companies like Royal Dutch Shell and Halliburton. Gareth first came to the healthcare industry in 2006 when he was appointed Baxter Healthcare’s Senior Counsel, India & South East Asia. Between 2009 – May 2015, Gareth served as Allergan’s General Counsel & Chief Compliance Officer, Asia Pacific.

Emmanuel is a Partner in EY Forensics practice in Asia-Pacific, which includes professionals who are forensic accountants, construction engineers, computer forensic specialists and data analysts. Before taking this role, he led the Forensics practice in Greater China.

He helps companies and their legal advisers deal with complex issues of fraud, corruption, regulatory compliance and business disputes. In the life sciences sector, Emmanuel has led numerous enquiries involving suspected improper practices by medical representatives, third party vendors and distributors.

Emmanuel has over 23 years of experience in fraud and financial statement investigations, anti-bribery/anti-corruption reviews, transactions forensics and litigation support, including 20 years in Hong Kong and Shanghai. He has also given evidence on accounting and valuation questions in arbitration proceedings.

Before coming to Asia in 1997, he worked in Paris on litigation support, due diligence and statutory audits.